CYTSA-RET fusions in spindle cell tumors [23] and uterine cervical sarcoma [24], CYTSA-NTRK fusions in pediatric sarcoma and brain tumors [25], and mesenchymal tumors of the gastrointestinal tracts [26] have been described. Here, SPECC1L is linked to spindle cell neoplasm.